Literature DB >> 15890989

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry.

Mathew J Reeves1, Shalini Arora, Joseph P Broderick, Michael Frankel, John P Heinrich, Susan Hickenbottom, Herbert Karp, Kenneth A LaBresh, Ann Malarcher, G Mensah, Charles J Moomaw, Lee Schwamm, Paul Weiss.   

Abstract

BACKGROUND AND
PURPOSE: The Paul Coverdell National Acute Stroke Registry is being developed to improve the quality of acute stroke care. This article describes key features of acute stroke care from 4 prototype registries in Georgia (Ga), Massachusetts (Mass), Michigan (Mich), and Ohio.
METHODS: Each prototype developed its own sampling scheme to obtain a representative sample of hospitals. Acute stroke admissions were identified using prospective (Mass, Mich) or retrospective (Ga, Ohio) methods. All prototypes used a common set of case definitions and data elements. Weighted site-specific frequencies were generated for each outcome.
RESULTS: A total of 6867 admissions from 98 hospitals were included; the majority were ischemic strokes (range, 52% to 70%) with transient ischemic attack and intracerebral hemorrhage comprising the bulk of the remainder. Between 19% and 26% of admissions were younger than age 60 years, and between 52% and 58% were female. Black subjects varied from 7.1% (Mich) to 30.6% (Ga). Between 20% and 25% of admissions arrived at the emergency department within 3 hours of onset. Treatment with recombinant tissue plasminogen activator (rtPA) was administered to between 3.0% (Ga) and 8.5% (Mass) of ischemic stroke admissions. Of 118 subjects treated with intravenous rtPA, <20% received it within 60 minutes of arrival. Compliance with secondary prevention practices was poorest for smoking cessation counseling and best for antithrombotics.
CONCLUSIONS: A minority of acute stroke patients are treated according to established guidelines. Quality improvement interventions, targeted primarily at the health care systems level, are needed to improve acute stroke care in the United States.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890989     DOI: 10.1161/01.STR.0000165902.18021.5b

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  119 in total

1.  Thymosin beta4: a candidate for treatment of stroke?

Authors:  Daniel C Morris; Michael Chopp; Li Zhang; Zheng G Zhang
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

2.  Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke be Extended to 4.5 Hours?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2009-05

3.  A cluster-randomized trial to improve stroke care in hospitals.

Authors:  K Lakshminarayan; C Borbas; B McLaughlin; N E Morris; G Vazquez; R V Luepker; D C Anderson
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

4.  Penalized Estimating Functions and Variable Selection in Semiparametric Regression Models.

Authors:  Brent A Johnson; D Y Lin; Donglin Zeng
Journal:  J Am Stat Assoc       Date:  2008-06-01       Impact factor: 5.033

5.  Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction.

Authors:  Michael J Lyerly; J Thomas Houston; Amelia K Boehme; Karen C Albright; Reza Bavarsad Shahripour; Paola Palazzo; Muhammed Alvi; Pawan V Rawal; Niren Kapoor; April Sisson; Anne W Alexandrov; Andrei V Alexandrov
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-03-28       Impact factor: 2.136

6.  Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

7.  Sex Disparities in Access to Acute Stroke Care: Can Telemedicine Mitigate this Effect?

Authors:  Catherine Wolff; Amelia K Boehme; Karen C Albright; Tzu-Ching Wu; Michael T Mullen; Charles C Branas; James C Grotta; Sean I Savitz; Brendan G Carr
Journal:  J Health Dispar Res Pract       Date:  2016

8.  Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke (THRIVES) study: qualitative phase protocol.

Authors:  Mayowa O Owolabi; Rufus O Akinyemi; Samantha Hurst; Oyedunni Arulogun; Olanrewaju Olaniyan; Mulugeta Gebregziabher; Babatunde L Salako; Bruce Ovbiagele
Journal:  Crit Pathw Cardiol       Date:  2014-03

9.  Thrombolysis in acute ischaemic stroke: an update.

Authors:  Thompson Robinson; Zahid Zaheer; Amit K Mistri
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

10.  Patient refusal of thrombolytic therapy for suspected acute ischemic stroke.

Authors:  F S Vahidy; M H Rahbar; A P Lal; J C Grotta; S I Savitz
Journal:  Int J Stroke       Date:  2012-12-11       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.